{
  "trial_id": "NCT00217672",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, ECOG performance status, HER2 status, prior adjuvant chemotherapy, prior endocrine therapy, measurable lesion status, life expectancy, absolute neutrophil count, platelet count, hemoglobin level, creatinine level, total bilirubin level, alkaline phosphatase level, AST level, ALT level, presence of neuropathy, cardiovascular disease history, gastrointestinal condition history, infection status, pregnancy status, hypersensitivity reaction history, proteinuria status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Hormone receptor status",
          "HER2 status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Number of metastatic sites"
      ],
      "remaining_candidate_features": [
        "ECOG performance status",
        "prior adjuvant chemotherapy",
        "prior endocrine therapy",
        "measurable lesion status",
        "life expectancy",
        "absolute neutrophil count",
        "platelet count",
        "hemoglobin level",
        "creatinine level",
        "total bilirubin level",
        "alkaline phosphatase level",
        "AST level",
        "ALT level",
        "presence of neuropathy",
        "cardiovascular disease history",
        "gastrointestinal condition history",
        "infection status",
        "pregnancy status",
        "hypersensitivity reaction history",
        "proteinuria status"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Race/Ethnicity, Customized, Region of Enrollment, ECOG performance status, HER2 status, Prior adjuvant chemotherapy, Absolute neutrophil count, Platelet count, Hemoglobin, Creatinine, Total bilirubin, Alkaline phosphatase, AST, ALT,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Hormone receptor status",
          "HER2 status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Number of metastatic sites"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "ECOG performance status",
        "Prior adjuvant chemotherapy",
        "Absolute neutrophil count",
        "Platelet count",
        "Hemoglobin",
        "Creatinine",
        "Total bilirubin",
        "Alkaline phosphatase",
        "AST",
        "ALT"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, HER2 Status, Prior Adjuvant Chemotherapy, Prior Endocrine Therapy, Number of Metastatic Sites, Sites of Metastases, Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status, Baseline Hemoglobin, Baseline Absolute Neutrophil Count, Baseline Platelet Count, Baseline Creatinine, Baseline Total Bilirubin, Baseline Alkaline Phosphatase, Baseline Angiotensin Aspartate Aminotransferase (AST) or Alanine Aminotransferase (ALT).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Hormone receptor status",
          "HER2 Status"
        ],
        [
          "Number of metastatic sites",
          "Number of Metastatic Sites"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "ECOG Performance Status",
        "Prior Adjuvant Chemotherapy",
        "Prior Endocrine Therapy",
        "Sites of Metastases",
        "Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status",
        "Baseline Hemoglobin",
        "Baseline Absolute Neutrophil Count",
        "Baseline Platelet Count",
        "Baseline Creatinine",
        "Baseline Total Bilirubin",
        "Baseline Alkaline Phosphatase",
        "Baseline Angiotensin Aspartate Aminotransferase (AST) or Alanine Aminotransferase (ALT)"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, race, ECOG performance status, HER2 status, prior adjuvant chemotherapy, prior endocrine therapy, number and location of metastatic lesions, absolute neutrophil count, platelet count, hemoglobin, creatinine, total bilirubin, alkaline phosphatase, AST, ALT.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "ECOG performance status"
        ],
        [
          "Hormone receptor status",
          "HER2 status"
        ],
        [
          "Number of metastatic sites",
          "number and location of metastatic lesions"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "race",
        "prior adjuvant chemotherapy",
        "prior endocrine therapy",
        "absolute neutrophil count",
        "platelet count",
        "hemoglobin",
        "creatinine",
        "total bilirubin",
        "alkaline phosphatase",
        "AST",
        "ALT"
      ]
    }
  }
}